A drug used to
treat cutaneous T-cell lymphoma and peripheral T-cell
lymphoma that have already been treated with other
anticancer drugs. It is also being studied in the treatment
of other types of cancer.
Romidepsin blocks certain
enzymes, which may help kill cancer cells. It is a type of
depsipeptide and a type of histone deacetylase
inhibitor. Also called FR901228 and Istodax.